Clinical Trials Directory

Trials / Completed

CompletedNCT00868205

Coffee and In-vivo Oxidative Stress

The Relationship Between Short- and Mid-term Intake of Coffee on in Vivo Levels of Oxidative Stress Parameters in Healthy Adults.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
TNO · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Accepted

Summary

Food and beverage intake that leads to a decrease in the level of in vivo markers of oxidative stress indicates that such foods and beverages act as antioxidants (AOX) in humans. Coffee drinking at a high level (\> 900 ml/day) for a short period of time (1 week) has been shown to reduce DNA oxidative damage-as indicated by a decrease in the level of percent tail DNA (%T)- in study populations comprised mainly of young adults aged \< 30 years. It is not clear whether such findings remain present over a longer period of time, and to extend such findings across a population that is more representative of European adults who consume common daily intakes of coffee, which is a low-to-moderate daily intake level (\< 750 ml/day). As such, the investigators propose to determine the effect of drinking 3 and 5 cups of coffee per day (equivalent to 450 and 750 ml per day, respectively) for 8-weeks on markers of in vivo oxidative stress relative to control in a population of healthy adults free of chronic diseases aged 35 to 65 years. To ensure that overall health is considered, the investigators will also evaluate the effect on markers of cardiovascular health, inflammation, and glycemic control.

Detailed description

Objective: The main objective of the present study is to determine the short- and mid-term effects of a coffee, on oxidative stress parameters in humans. Study design: randomized, placebo-controlled, investigator-blinded, 3-arm parallel Study population: 168 apparently healthy volunteers: males and females aged \>=35 and \<= 65 years. Intervention: The treatments consist of daily consumption of either: Treatment 1: 0.45 L coffee (3 cups) and 0.30 L bottled water daily or; Treatment 2: 0.75 L coffee (5 cups) daily or; Treatment 3: 0.75 L water daily Duration of the treatment intervention is 8 weeks. Before the intervention period starts, a run-in period of five weeks where all subjects maintain their low antioxidant diet (Dutch average) is conducted by all subjects in order to standardize the antioxidant intake of the subjects. Main study parameters/endpoints: Mean level of %T as a measure of DNA oxidative damage at week 8. Secondary outcome is the mean level of 8-isoprostane in 24 hr urine.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCoffee consumption3 or 5 cups of coffee daily for eight weeks

Timeline

Start date
2009-03-01
Primary completion
2009-07-01
Completion
2010-03-01
First posted
2009-03-24
Last updated
2012-02-28

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00868205. Inclusion in this directory is not an endorsement.